Pandey Chandra Kant, Navkar Deepa Vishwas, Giri Pramod Janardan, Raza Mehdi, Behari Sanjay, Singh R B, Singh Uttam, Singh Prabhat Kumar
Department of Anaesthesiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
J Neurosurg Anesthesiol. 2005 Apr;17(2):65-8. doi: 10.1097/01.ana.0000151407.62650.51.
We evaluated the optimal preemptive dose of gabapentin for postoperative pain relief after single-level lumbar diskectomy and its effect on fentanyl consumption during the initial 24 hours in a randomized, double-blinded, placebo-controlled study in 100 patients with American Society of Anesthesiologists physical status I and II. Patients were divided into five groups to receive placebo or gabapentin 300, 600, 900, or 1200 mg 2 hours before surgery. After surgery, patients were transferred to the postanesthesia care unit (PACU). A blinded anesthesiologist recorded the pain scores at time points of 6, 12, 18, and 24 hours in the PACU on a Visual Analog Scale (VAS; 0-10 cm) at rest. Patients received patient-controlled analgesia (fentanyl 1.0 mug/kg on each demand with lockout interval of 10 minutes); total fentanyl consumption during initial 24 hours was recorded. Data were entered into the statistical software package SPSS 9.0 for analysis (one-way analysis of variance and Student-Newman-Keuls test). Patients who received gabapentin 300 mg had significantly lower VAS score at all time points. They consumed less fentanyl (patients who received placebo processed 1217.5 +/- 182.0 versus 987.5 +/- 129.6 mug; P < 0.05). Patients who received gabapentin 600, 900, and 1200 mg had lower VAS scores at all time points than patients who received gabapentin 300 mg (P < 0.05). Increasing the dose of gabapentin from 600 to 1200 mg did not decrease the VAS score, nor did the increasing dose of gabapentin significantly decrease fentanyl consumption (702.5, 635, and 626.5 microg). Thus, gabapentin 600 mg is the optimal dose for postoperative pain relief following lumbar diskectomy.
在一项针对100例美国麻醉医师协会身体状况分级为I级和II级的患者的随机、双盲、安慰剂对照研究中,我们评估了加巴喷丁用于单节段腰椎间盘切除术后疼痛缓解的最佳预充剂量及其对最初24小时内芬太尼消耗量的影响。患者被分为五组,在手术前2小时分别接受安慰剂或300、600、900或1200毫克加巴喷丁。手术后,患者被转移至麻醉后护理单元(PACU)。一名盲态的麻醉医师在PACU中于术后6、12、18和24小时记录静息状态下的视觉模拟评分(VAS;0 - 10厘米)疼痛评分。患者接受患者自控镇痛(每次按需给予芬太尼1.0微克/千克,锁定间隔为10分钟);记录最初24小时内的总芬太尼消耗量。数据录入统计软件包SPSS 9.0进行分析(单因素方差分析和Student - Newman - Keuls检验)。接受300毫克加巴喷丁的患者在所有时间点的VAS评分均显著更低。他们的芬太尼消耗量更少(接受安慰剂的患者消耗1217.5±182.0微克,而接受加巴喷丁的患者消耗987.5±129.6微克;P < 0.05)。接受600、900和1200毫克加巴喷丁的患者在所有时间点的VAS评分均低于接受300毫克加巴喷丁的患者(P < 0.05)。将加巴喷丁剂量从600毫克增加至1200毫克并未降低VAS评分,加巴喷丁剂量增加也未显著降低芬太尼消耗量(分别为702.5、635和626.5微克)。因此,600毫克加巴喷丁是腰椎间盘切除术后疼痛缓解的最佳剂量。